SAN FRANCISCO, June 12, 2026 (GLOBE NEWSWIRE) — Veyond Metaverse, a pioneer in 5D XR real-time immersive communication technology, announced today that it has closed a strategic investment from a Japan-based private investor. The new capital supports the company’s next phase of commercialization across aviation, maritime, offshore, and broader healthcare environments where access to specialist medical care has historically been constrained.
The investment follows a period of accelerating commercial and external validation for Veyond Metaverse. The company has established a global commercial framework with a strategic partner that is a leading worldwide provider of remote medical assistance, and has earned recognition as a Top 3 Finalist at the Crystal Cabin Awards in Hamburg alongside Delta Air Lines and United Airlines, a Silver Award at the 2026 Edison Awards in the United States, and Gold recognition at the 2025 Digital Health Awards in the Telehealth and Remote Patient Monitoring category. The company’s underlying technology is protected by a U.S. patent granted in 2025.
“For decades, the standard of medical care available to people in the air, at sea, and in remote environments has been constrained by what voice and basic data could carry,” said Adam Choe, CEO of Veyond Metaverse. “We are now in a position to change that standard at global scale. Welcoming international capital in the same period that we are establishing global commercial frameworks reflects where we are in that arc — moving from validation to deployment.”
A representative of the investor group commented: “Veyond Metaverse is primed to address mission-critical needs across multiple verticals. The need for real-time, expert-level medical support in remote and high-consequence environments is intensifying across broader healthcare — including surgical collaboration, remote specialist care, and medical training and education — as well as aviation, maritime, and offshore environments. Veyond Metaverse’s AI-powered 5D XR platform addresses this need with the technical depth and commercial path we look for, with clear runway for deployment across multiple verticals.”
The capital will support continued product engineering, infrastructure scaling, and commercial roll-out across the company’s XR medical telepresence platform.
About Veyond Metaverse
Veyond Metaverse is a San Francisco–based 5D XR technology company delivering AI-powered real-time immersive communication platforms for healthcare, aviation, maritime, and offshore sectors. Its technology enables expert-level medical guidance, training, and collaboration anywhere in the world, with a focus on environments where access to specialist care is constrained by distance, infrastructure, or time.
Media Contact: [email protected] | www.veyondmetaverse.com
Forward-Looking Statements
This release contains forward-looking statements subject to risks and uncertainties. Actual results may differ materially from those projected.
Disclaimer: This content is provided by Veyond Metaverse. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or business advice. All investments carry inherent risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any inaccuracies, misrepresentations, or financial losses resulting from the use or reliance on the information in this press release. Speculate only with funds you can afford to lose. In the event of any legal claims or concerns regarding this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.
Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without warranties or representations of any kind, express or implied. We assume no responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained herein. Any complaints, copyright issues, or inquiries regarding this article should be directed to the content provider listed above.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8d5ad0ae-ac0d-4097-970a-000edde4ae19
